• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量抑肽酶与自体新鲜全血输血用于体外循环后减少失血及血液使用量的比较

Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin versus autologous fresh whole blood transfusion.

作者信息

Vedrinne C, Girard C, Jegaden O, Blanc P, Bouvier H, Ffrench P, Mikaeloff P, Estanove S

机构信息

Department of Anesthesiology and Intensive Care, Hôpital Cardiologique Louis Pradel, Lepine, France.

出版信息

J Cardiothorac Vasc Anesth. 1992 Jun;6(3):319-23. doi: 10.1016/1053-0770(92)90149-2.

DOI:10.1016/1053-0770(92)90149-2
PMID:1377035
Abstract

Ninety patients undergoing cardiac surgery were randomly divided into three groups of 30 patients to compare the effects on bleeding and transfusion requirements of either intraoperative infusion of high-dose aprotinin (GpI) or reinfusion of autologous fresh whole blood (GpII) versus a control group (GpIII). Standardized anesthetic, perfusion, and surgical techniques were used. Platelet counts, hemoglobin concentration, hematocrit, fibrinogen, and Ivy-Nelson bleeding times determined at fixed times perioperatively did not differ among the three groups. The total loss from the chest drains was significantly reduced in GpI (328 +/- 28 mL; mean +/- SEM) as compared with the loss in GpII and GpIII (775 +/- 75 mL and 834 +/- 68 mL, respectively). There was a threefold difference in the total hemoglobin loss (GpI, 14.2 +/- 1.7 g; GpII, 50.1 +/- 5.0 g; GpIII, 45.0 +/- 5.2 g). GpI patients also received less banked blood: 250 +/- 53 mL versus 507 +/- 95 mL in GpII and 557 +/- 75 mL in GpIII. No GpI patient required transfusion of platelets or fresh frozen plasma. Fresh whole autologous blood transfusions had no significant hemostatic effect and failed to reduce the homologous blood requirement. Conversely, high-dose aprotinin reduced blood loss and transfusion requirements.

摘要

90例行心脏手术的患者被随机分为三组,每组30例,以比较术中输注大剂量抑肽酶(第一组)或自体新鲜全血回输(第二组)与对照组(第三组)对出血及输血需求的影响。采用标准化的麻醉、灌注和手术技术。三组患者围手术期固定时间点测定的血小板计数、血红蛋白浓度、血细胞比容、纤维蛋白原及Ivy-Nelson出血时间无差异。与第二组和第三组(分别为775±75ml和834±68ml)相比,第一组胸腔引流管的总失血量显著减少(328±28ml)。总血红蛋白丢失量有三倍差异(第一组,14.2±1.7g;第二组,50.1±5.0g;第三组,45.0±5.2g)。第一组患者输注的库存血也较少:250±53ml,而第二组为507±95ml,第三组为557±75ml。第一组患者均无需输注血小板或新鲜冰冻血浆。自体新鲜全血回输无显著止血作用,也未能减少异体血需求。相反,大剂量抑肽酶可减少失血量和输血需求。

相似文献

1
Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin versus autologous fresh whole blood transfusion.大剂量抑肽酶与自体新鲜全血输血用于体外循环后减少失血及血液使用量的比较
J Cardiothorac Vasc Anesth. 1992 Jun;6(3):319-23. doi: 10.1016/1053-0770(92)90149-2.
2
Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).大剂量抑肽酶(特血乐)用于体外循环后减少失血及输血量。
J Thorac Cardiovasc Surg. 1989 Mar;97(3):364-72.
3
Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.心脏手术中的术中抗纤溶和血液保护技术。三种抗纤溶药物的前瞻性试验。
Tex Heart Inst J. 1995;22(3):231-6.
4
A comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing cardiac surgery.氨甲环酸与低剂量抑肽酶对心脏手术患者失血及同种异体血使用影响的比较。
J Cardiothorac Vasc Anesth. 1995 Jun;9(3):240-4. doi: 10.1016/s1053-0770(05)80314-3.
5
Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery.自体血液回收机与低剂量抑肽酶对瓣膜手术患者失血及同种异体血使用影响的比较。
J Cardiothorac Vasc Anesth. 2001 Jun;15(3):326-30. doi: 10.1053/jcan.2001.23282.
6
Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.大剂量抑肽酶对体外循环后失血、血小板功能、纤维蛋白溶解、补体及肾功能的影响。
J Thorac Cardiovasc Surg. 1991 Jun;101(6):958-67.
7
Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.
Can J Anaesth. 1993 Jul;40(7):625-31. doi: 10.1007/BF03009699.
8
High-dose aprotinin application reduces homologous blood requirement in cardiac surgery.大剂量应用抑肽酶可减少心脏手术中同种异体血的需求量。
J Cardiothorac Anesth. 1989 Oct;3(5 Suppl 1):79. doi: 10.1016/0888-6296(89)90822-3.
9
Randomized placebo-controlled double-blind study of three aprotinin regimens in primary cardiac surgery.三种抑肽酶方案用于心脏直视手术的随机安慰剂对照双盲研究
Br J Surg. 1994 Jul;81(7):969-73. doi: 10.1002/bjs.1800810713.
10
The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.两种不同剂量的抑肽酶对体外循环心脏手术中止血的影响:输血需求和失血量相似。
Haematologica. 2000 Dec;85(12):1277-84.

引用本文的文献

1
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.抗纤溶药物用于减少围手术期异体输血。
Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD001886. doi: 10.1002/14651858.CD001886.pub4.
2
The hemostatic defect of cardiopulmonary bypass.体外循环的止血缺陷。
J Thromb Thrombolysis. 2003 Dec;16(3):129-47. doi: 10.1023/B:THRO.0000024051.12177.e9.
3
Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial.心脏手术中减少输血的机械方法:随机对照试验
BMJ. 2002 Jun 1;324(7349):1299. doi: 10.1136/bmj.324.7349.1299.